Which of the following is a characteristic of praziquantel when treating schistosomiasis?

Praziquantel is a well-established treatment for schistosomiasis, a disease caused by parasitic worms belonging to the genus Schistosoma. One of the defining characteristics of praziquantel is its effectiveness as a single-dose treatment. This feature is particularly advantageous for managing schistosomiasis, as it simplifies the treatment regimen for patients and increases compliance. The ease of administration with just one dose can help in reducing the burden of illness and improving public health outcomes in regions where schistosomiasis is endemic.

In contrast, some other treatments for parasitic infections may require prolonged courses or multiple doses, making praziquantel's single-dose option distinct and beneficial. Its pharmacological mode of action also allows it to efficiently damage the parasite's tegument, facilitating its clearance from the body.

Ultimately, the efficacy of praziquantel in a single dose for schistosomiasis underscores its utility and effectiveness in treating this infection.